Pateint with ige increase but still on immunosuppresants and having allergy with water not tolerate cold s

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Based on your clinical description — elevated IgE, on immunosuppressants, intolerance to water and cold — this presentation fits a pattern of chronic inducible urticaria, most likely involving aquagenic urticaria and/or cold urticaria, with elevated IgE suggesting an atopic/allergic background. Here is a structured breakdown:

Clinical Picture

FeatureInterpretation
↑ IgEAtopic/allergic predisposition; suggests mast cell sensitisation
Intolerance to water (any temp)Aquagenic urticaria
Intolerance to coldCold urticaria (may co-exist)
On immunosuppressantsTreatment-refractory chronic inducible urticaria
These two can coexist — cold urticaria is triggered by cold water/air, while aquagenic urticaria is triggered by water regardless of temperature.

Aquagenic Urticaria

  • Rare subtype of chronic inducible urticaria
  • Triggered by skin contact with water at any temperature — this distinguishes it from cold/heat urticaria
  • Produces small papular wheals with wide surrounding flares, resembling cholinergic urticaria but fewer in number
  • Lesions typically resolve within <1 hour
  • Must be differentiated from aquagenic pruritus (pruritus without wheals)
  • Fitzpatrick's Dermatology, Vol. 1; Dermatology 2-Volume Set 5e

Cold Urticaria

  • Triggered by cold exposure (cold water, cold air, cold objects)
  • Can overlap with aquagenic urticaria — cold water may trigger both simultaneously
  • Can cause anaphylaxis in severe cases (especially with cold immersion — swimming)
  • Diagnosed by ice cube test (TempTest)
  • Washington Manual of Medical Therapeutics

Why IgE is Elevated Despite Immunosuppression

  • Immunosuppressants (e.g., cyclosporine, azathioprine, mycophenolate) suppress cellular immunity and reduce overall inflammatory burden but do not directly suppress IgE production (which is a B-cell/plasma cell mediated, IL-4/IL-13 driven process)
  • In atopic patients, IgE can remain persistently elevated even on immunosuppression
  • Mast cell activation (the effector mechanism of urticaria) can still occur via IgE-receptor crosslinking even when T-cell mediated immunity is suppressed
  • This explains a patient who is "controlled" on immunosuppressants but still has IgE-mediated urticarial reactions

Management Considerations

For urticaria refractory to standard therapy:
  1. First-line: Non-sedating H1 antihistamines (up to 4× standard dose — cetirizine, fexofenadine, loratadine)
  2. Second-line: Omalizumab (anti-IgE monoclonal antibody) — especially relevant here given elevated IgE
    • Targets free IgE and downregulates FcεRI on mast cells
    • Effective in both chronic spontaneous and chronic inducible urticaria
    • Particularly useful when IgE is elevated and conventional immunosuppression is insufficient
  3. Current immunosuppressants (cyclosporine, etc.) act via T-cell suppression and are less targeted for IgE-mast cell axis
  4. Trigger avoidance: Protective clothing, avoiding cold water immersion, lukewarm baths

Key Distinction

Aquagenic UrticariaCold Urticaria
TriggerWater (any temp)Cold stimulus
IgE involvementVariableOften IgE-mediated
Risk of anaphylaxisRareYes (cold immersion)
TreatmentAntihistamines, omalizumabAntihistamines, omalizumab

Bottom line: This patient has chronic inducible urticaria (aquagenic ± cold) with an atopic background (elevated IgE). Conventional immunosuppression does not adequately target the IgE-mast cell axis. Omalizumab (anti-IgE therapy) is the most mechanistically appropriate escalation for this refractory presentation.
This is a shared conversation. Sign in to Orris to start your own chat.